1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Small Molecule Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Chemotherapy Drugs
1.2.3 Immunomodulating Drugs
1.2.4 Targeted Therapy Drugs
1.2.5 Hormonal Therapy
1.2.6 Other
1.3 Market by Application
1.3.1 Global Oncology Small Molecule Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Lung Cancer
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Oncology Small Molecule Drugs Market Perspective (2017-2028)
2.2 Oncology Small Molecule Drugs Growth Trends by Region
2.2.1 Oncology Small Molecule Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Oncology Small Molecule Drugs Historic Market Size by Region (2017-2022)
2.2.3 Oncology Small Molecule Drugs Forecasted Market Size by Region (2023-2028)
2.3 Oncology Small Molecule Drugs Market Dynamics
2.3.1 Oncology Small Molecule Drugs Industry Trends
2.3.2 Oncology Small Molecule Drugs Market Drivers
2.3.3 Oncology Small Molecule Drugs Market Challenges
2.3.4 Oncology Small Molecule Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology Small Molecule Drugs Players by Revenue
3.1.1 Global Top Oncology Small Molecule Drugs Players by Revenue (2017-2022)
3.1.2 Global Oncology Small Molecule Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Oncology Small Molecule Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oncology Small Molecule Drugs Revenue
3.4 Global Oncology Small Molecule Drugs Market Concentration Ratio
3.4.1 Global Oncology Small Molecule Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Small Molecule Drugs Revenue in 2021
3.5 Oncology Small Molecule Drugs Key Players Head office and Area Served
3.6 Key Players Oncology Small Molecule Drugs Product Solution and Service
3.7 Date of Enter into Oncology Small Molecule Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Small Molecule Drugs Breakdown Data by Type
4.1 Global Oncology Small Molecule Drugs Historic Market Size by Type (2017-2022)
4.2 Global Oncology Small Molecule Drugs Forecasted Market Size by Type (2023-2028)
5 Oncology Small Molecule Drugs Breakdown Data by Application
5.1 Global Oncology Small Molecule Drugs Historic Market Size by Application (2017-2022)
5.2 Global Oncology Small Molecule Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Oncology Small Molecule Drugs Market Size (2017-2028)
6.2 North America Oncology Small Molecule Drugs Market Size by Type
6.2.1 North America Oncology Small Molecule Drugs Market Size by Type (2017-2022)
6.2.2 North America Oncology Small Molecule Drugs Market Size by Type (2023-2028)
6.2.3 North America Oncology Small Molecule Drugs Market Share by Type (2017-2028)
6.3 North America Oncology Small Molecule Drugs Market Size by Application
6.3.1 North America Oncology Small Molecule Drugs Market Size by Application (2017-2022)
6.3.2 North America Oncology Small Molecule Drugs Market Size by Application (2023-2028)
6.3.3 North America Oncology Small Molecule Drugs Market Share by Application (2017-2028)
6.4 North America Oncology Small Molecule Drugs Market Size by Country
6.4.1 North America Oncology Small Molecule Drugs Market Size by Country (2017-2022)
6.4.2 North America Oncology Small Molecule Drugs Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Oncology Small Molecule Drugs Market Size (2017-2028)
7.2 Europe Oncology Small Molecule Drugs Market Size by Type
7.2.1 Europe Oncology Small Molecule Drugs Market Size by Type (2017-2022)
7.2.2 Europe Oncology Small Molecule Drugs Market Size by Type (2023-2028)
7.2.3 Europe Oncology Small Molecule Drugs Market Share by Type (2017-2028)
7.3 Europe Oncology Small Molecule Drugs Market Size by Application
7.3.1 Europe Oncology Small Molecule Drugs Market Size by Application (2017-2022)
7.3.2 Europe Oncology Small Molecule Drugs Market Size by Application (2023-2028)
7.3.3 Europe Oncology Small Molecule Drugs Market Share by Application (2017-2028)
7.4 Europe Oncology Small Molecule Drugs Market Size by Country
7.4.1 Europe Oncology Small Molecule Drugs Market Size by Country (2017-2022)
7.4.2 Europe Oncology Small Molecule Drugs Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncology Small Molecule Drugs Market Size (2017-2028)
8.2 Asia-Pacific Oncology Small Molecule Drugs Market Size by Type
8.2.1 Asia-Pacific Oncology Small Molecule Drugs Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Oncology Small Molecule Drugs Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Oncology Small Molecule Drugs Market Share by Type (2017-2028)
8.3 Asia-Pacific Oncology Small Molecule Drugs Market Size by Application
8.3.1 Asia-Pacific Oncology Small Molecule Drugs Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Oncology Small Molecule Drugs Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Oncology Small Molecule Drugs Market Share by Application (2017-2028)
8.4 Asia-Pacific Oncology Small Molecule Drugs Market Size by Region
8.4.1 Asia-Pacific Oncology Small Molecule Drugs Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Oncology Small Molecule Drugs Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Oncology Small Molecule Drugs Market Size (2017-2028)
9.2 Latin America Oncology Small Molecule Drugs Market Size by Type
9.2.1 Latin America Oncology Small Molecule Drugs Market Size by Type (2017-2022)
9.2.2 Latin America Oncology Small Molecule Drugs Market Size by Type (2023-2028)
9.2.3 Latin America Oncology Small Molecule Drugs Market Share by Type (2017-2028)
9.3 Latin America Oncology Small Molecule Drugs Market Size by Application
9.3.1 Latin America Oncology Small Molecule Drugs Market Size by Application (2017-2022)
9.3.2 Latin America Oncology Small Molecule Drugs Market Size by Application (2023-2028)
9.3.3 Latin America Oncology Small Molecule Drugs Market Share by Application (2017-2028)
9.4 Latin America Oncology Small Molecule Drugs Market Size by Country
9.4.1 Latin America Oncology Small Molecule Drugs Market Size by Country (2017-2022)
9.4.2 Latin America Oncology Small Molecule Drugs Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology Small Molecule Drugs Market Size (2017-2028)
10.2 Middle East & Africa Oncology Small Molecule Drugs Market Size by Type
10.2.1 Middle East & Africa Oncology Small Molecule Drugs Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Oncology Small Molecule Drugs Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Oncology Small Molecule Drugs Market Share by Type (2017-2028)
10.3 Middle East & Africa Oncology Small Molecule Drugs Market Size by Application
10.3.1 Middle East & Africa Oncology Small Molecule Drugs Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Oncology Small Molecule Drugs Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Oncology Small Molecule Drugs Market Share by Application (2017-2028)
10.4 Middle East & Africa Oncology Small Molecule Drugs Market Size by Country
10.4.1 Middle East & Africa Oncology Small Molecule Drugs Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Oncology Small Molecule Drugs Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Oncology Small Molecule Drugs Introduction
11.1.4 Roche Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.1.5 Roche Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Oncology Small Molecule Drugs Introduction
11.2.4 Novartis Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.2.5 Novartis Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Oncology Small Molecule Drugs Introduction
11.3.4 Pfizer Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.3.5 Pfizer Recent Developments
11.4 Celgene
11.4.1 Celgene Company Details
11.4.2 Celgene Business Overview
11.4.3 Celgene Oncology Small Molecule Drugs Introduction
11.4.4 Celgene Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.4.5 Celgene Recent Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Oncology Small Molecule Drugs Introduction
11.5.4 Bristol-Myers Squibb Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.5.5 Bristol-Myers Squibb Recent Developments
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Oncology Small Molecule Drugs Introduction
11.6.4 Amgen Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.6.5 Amgen Recent Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Oncology Small Molecule Drugs Introduction
11.7.4 Johnson & Johnson Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.7.5 Johnson & Johnson Recent Developments
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Oncology Small Molecule Drugs Introduction
11.8.4 AbbVie Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.8.5 AbbVie Recent Developments
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Oncology Small Molecule Drugs Introduction
11.9.4 Sanofi Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.9.5 Sanofi Recent Developments
11.10 Takeda
11.10.1 Takeda Company Details
11.10.2 Takeda Business Overview
11.10.3 Takeda Oncology Small Molecule Drugs Introduction
11.10.4 Takeda Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.10.5 Takeda Recent Developments
11.11 Eli Lilly
11.11.1 Eli Lilly Company Details
11.11.2 Eli Lilly Business Overview
11.11.3 Eli Lilly Oncology Small Molecule Drugs Introduction
11.11.4 Eli Lilly Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.11.5 Eli Lilly Recent Developments
11.12 Bayer
11.12.1 Bayer Company Details
11.12.2 Bayer Business Overview
11.12.3 Bayer Oncology Small Molecule Drugs Introduction
11.12.4 Bayer Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.12.5 Bayer Recent Developments
11.13 AstraZeneca
11.13.1 AstraZeneca Company Details
11.13.2 AstraZeneca Business Overview
11.13.3 AstraZeneca Oncology Small Molecule Drugs Introduction
11.13.4 AstraZeneca Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.13.5 AstraZeneca Recent Developments
11.14 Astellas
11.14.1 Astellas Company Details
11.14.2 Astellas Business Overview
11.14.3 Astellas Oncology Small Molecule Drugs Introduction
11.14.4 Astellas Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.14.5 Astellas Recent Developments
11.15 Merck
11.15.1 Merck Company Details
11.15.2 Merck Business Overview
11.15.3 Merck Oncology Small Molecule Drugs Introduction
11.15.4 Merck Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.15.5 Merck Recent Developments
11.16 Biogen Idec
11.16.1 Biogen Idec Company Details
11.16.2 Biogen Idec Business Overview
11.16.3 Biogen Idec Oncology Small Molecule Drugs Introduction
11.16.4 Biogen Idec Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.16.5 Biogen Idec Recent Developments
11.17 Eisai
11.17.1 Eisai Company Details
11.17.2 Eisai Business Overview
11.17.3 Eisai Oncology Small Molecule Drugs Introduction
11.17.4 Eisai Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.17.5 Eisai Recent Developments
11.18 Teva
11.18.1 Teva Company Details
11.18.2 Teva Business Overview
11.18.3 Teva Oncology Small Molecule Drugs Introduction
11.18.4 Teva Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.18.5 Teva Recent Developments
11.19 Otsuka
11.19.1 Otsuka Company Details
11.19.2 Otsuka Business Overview
11.19.3 Otsuka Oncology Small Molecule Drugs Introduction
11.19.4 Otsuka Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.19.5 Otsuka Recent Developments
11.20 Ipsen
11.20.1 Ipsen Company Details
11.20.2 Ipsen Business Overview
11.20.3 Ipsen Oncology Small Molecule Drugs Introduction
11.20.4 Ipsen Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.20.5 Ipsen Recent Developments
11.21 Gilead Sciences
11.21.1 Gilead Sciences Company Details
11.21.2 Gilead Sciences Business Overview
11.21.3 Gilead Sciences Oncology Small Molecule Drugs Introduction
11.21.4 Gilead Sciences Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.21.5 Gilead Sciences Recent Developments
11.22 Exelixis
11.22.1 Exelixis Company Details
11.22.2 Exelixis Business Overview
11.22.3 Exelixis Oncology Small Molecule Drugs Introduction
11.22.4 Exelixis Revenue in Oncology Small Molecule Drugs Business (2017-2022)
11.22.5 Exelixis Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Oncology Small Molecule Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Chemotherapy Drugs
Table 3. Key Players of Immunomodulating Drugs
Table 4. Key Players of Targeted Therapy Drugs
Table 5. Key Players of Hormonal Therapy
Table 6. Key Players of Other
Table 7. Global Oncology Small Molecule Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Oncology Small Molecule Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Oncology Small Molecule Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Oncology Small Molecule Drugs Market Share by Region (2017-2022)
Table 11. Global Oncology Small Molecule Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Oncology Small Molecule Drugs Market Share by Region (2023-2028)
Table 13. Oncology Small Molecule Drugs Market Trends
Table 14. Oncology Small Molecule Drugs Market Drivers
Table 15. Oncology Small Molecule Drugs Market Challenges
Table 16. Oncology Small Molecule Drugs Market Restraints
Table 17. Global Oncology Small Molecule Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Oncology Small Molecule Drugs Revenue Share by Players (2017-2022)
Table 19. Global Top Oncology Small Molecule Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Small Molecule Drugs as of 2021)
Table 20. Ranking of Global Top Oncology Small Molecule Drugs Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Oncology Small Molecule Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Oncology Small Molecule Drugs Product Solution and Service
Table 24. Date of Enter into Oncology Small Molecule Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Oncology Small Molecule Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Oncology Small Molecule Drugs Revenue Market Share by Type (2017-2022)
Table 28. Global Oncology Small Molecule Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Oncology Small Molecule Drugs Revenue Market Share by Type (2023-2028)
Table 30. Global Oncology Small Molecule Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Oncology Small Molecule Drugs Revenue Share by Application (2017-2022)
Table 32. Global Oncology Small Molecule Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Oncology Small Molecule Drugs Revenue Share by Application (2023-2028)
Table 34. North America Oncology Small Molecule Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Oncology Small Molecule Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Oncology Small Molecule Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Oncology Small Molecule Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Oncology Small Molecule Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Oncology Small Molecule Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Oncology Small Molecule Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Oncology Small Molecule Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Oncology Small Molecule Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Oncology Small Molecule Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Oncology Small Molecule Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Oncology Small Molecule Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Oncology Small Molecule Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Oncology Small Molecule Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Oncology Small Molecule Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Oncology Small Molecule Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Oncology Small Molecule Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Oncology Small Molecule Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Oncology Small Molecule Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Oncology Small Molecule Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Oncology Small Molecule Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Oncology Small Molecule Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Oncology Small Molecule Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Oncology Small Molecule Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Oncology Small Molecule Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Oncology Small Molecule Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Oncology Small Molecule Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Oncology Small Molecule Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Oncology Small Molecule Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Oncology Small Molecule Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 64. Roche Company Details
Table 65. Roche Business Overview
Table 66. Roche Oncology Small Molecule Drugs Product
Table 67. Roche Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 68. Roche Recent Developments
Table 69. Novartis Company Details
Table 70. Novartis Business Overview
Table 71. Novartis Oncology Small Molecule Drugs Product
Table 72. Novartis Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 73. Novartis Recent Developments
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer Oncology Small Molecule Drugs Product
Table 77. Pfizer Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 78. Pfizer Recent Developments
Table 79. Celgene Company Details
Table 80. Celgene Business Overview
Table 81. Celgene Oncology Small Molecule Drugs Product
Table 82. Celgene Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 83. Celgene Recent Developments
Table 84. Bristol-Myers Squibb Company Details
Table 85. Bristol-Myers Squibb Business Overview
Table 86. Bristol-Myers Squibb Oncology Small Molecule Drugs Product
Table 87. Bristol-Myers Squibb Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 88. Bristol-Myers Squibb Recent Developments
Table 89. Amgen Company Details
Table 90. Amgen Business Overview
Table 91. Amgen Oncology Small Molecule Drugs Product
Table 92. Amgen Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 93. Amgen Recent Developments
Table 94. Johnson & Johnson Company Details
Table 95. Johnson & Johnson Business Overview
Table 96. Johnson & Johnson Oncology Small Molecule Drugs Product
Table 97. Johnson & Johnson Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 98. Johnson & Johnson Recent Developments
Table 99. AbbVie Company Details
Table 100. AbbVie Business Overview
Table 101. AbbVie Oncology Small Molecule Drugs Product
Table 102. AbbVie Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 103. AbbVie Recent Developments
Table 104. Sanofi Company Details
Table 105. Sanofi Business Overview
Table 106. Sanofi Oncology Small Molecule Drugs Product
Table 107. Sanofi Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 108. Sanofi Recent Developments
Table 109. Takeda Company Details
Table 110. Takeda Business Overview
Table 111. Takeda Oncology Small Molecule Drugs Product
Table 112. Takeda Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 113. Takeda Recent Developments
Table 114. Eli Lilly Company Details
Table 115. Eli Lilly Business Overview
Table 116. Eli Lilly Oncology Small Molecule Drugs Product
Table 117. Eli Lilly Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 118. Eli Lilly Recent Developments
Table 119. Bayer Company Details
Table 120. Bayer Business Overview
Table 121. Bayer Oncology Small Molecule Drugs Product
Table 122. Bayer Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 123. Bayer Recent Developments
Table 124. AstraZeneca Company Details
Table 125. AstraZeneca Business Overview
Table 126. AstraZeneca Oncology Small Molecule Drugs Product
Table 127. AstraZeneca Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 128. AstraZeneca Recent Developments
Table 129. Astellas Company Details
Table 130. Astellas Business Overview
Table 131. Astellas Oncology Small Molecule Drugs Product
Table 132. Astellas Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 133. Astellas Recent Developments
Table 134. Merck Company Details
Table 135. Merck Business Overview
Table 136. Merck Oncology Small Molecule Drugs Product
Table 137. Merck Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 138. Merck Recent Developments
Table 139. Biogen Idec Company Details
Table 140. Biogen Idec Business Overview
Table 141. Biogen Idec Oncology Small Molecule Drugs Product
Table 142. Biogen Idec Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 143. Biogen Idec Recent Developments
Table 144. Eisai Company Details
Table 145. Eisai Business Overview
Table 146. Eisai Oncology Small Molecule Drugs Product
Table 147. Eisai Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 148. Eisai Recent Developments
Table 149. Teva Company Details
Table 150. Teva Business Overview
Table 151. Teva Oncology Small Molecule Drugs Product
Table 152. Teva Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 153. Teva Recent Developments
Table 154. Otsuka Company Details
Table 155. Otsuka Business Overview
Table 156. Otsuka Oncology Small Molecule Drugs Product
Table 157. Otsuka Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 158. Otsuka Recent Developments
Table 159. Ipsen Company Details
Table 160. Ipsen Business Overview
Table 161. Ipsen Oncology Small Molecule Drugs Product
Table 162. Ipsen Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 163. Ipsen Recent Developments
Table 164. Gilead Sciences Company Details
Table 165. Gilead Sciences Business Overview
Table 166. Gilead Sciences Oncology Small Molecule Drugs Product
Table 167. Gilead Sciences Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 168. Gilead Sciences Recent Developments
Table 169. Exelixis Company Details
Table 170. Exelixis Business Overview
Table 171. Exelixis Oncology Small Molecule Drugs Product
Table 172. Exelixis Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
Table 173. Exelixis Recent Developments
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncology Small Molecule Drugs Market Share by Type: 2021 VS 2028
Figure 2. Chemotherapy Drugs Features
Figure 3. Immunomodulating Drugs Features
Figure 4. Targeted Therapy Drugs Features
Figure 5. Hormonal Therapy Features
Figure 6. Other Features
Figure 7. Global Oncology Small Molecule Drugs Market Share by Application: 2021 VS 2028
Figure 8. Blood Cancer Case Studies
Figure 9. Breast Cancer Case Studies
Figure 10. Gastrointestinal Cancer Case Studies
Figure 11. Prostate Cancer Case Studies
Figure 12. Lung Cancer Case Studies
Figure 13. Other Case Studies
Figure 14. Oncology Small Molecule Drugs Report Years Considered
Figure 15. Global Oncology Small Molecule Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 16. Global Oncology Small Molecule Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Oncology Small Molecule Drugs Market Share by Region: 2021 VS 2028
Figure 18. Global Oncology Small Molecule Drugs Market Share by Players in 2021
Figure 19. Global Top Oncology Small Molecule Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Small Molecule Drugs as of 2021)
Figure 20. The Top 10 and 5 Players Market Share by Oncology Small Molecule Drugs Revenue in 2021
Figure 21. North America Oncology Small Molecule Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 22. North America Oncology Small Molecule Drugs Market Size Market Share by Type (2017-2028)
Figure 23. North America Oncology Small Molecule Drugs Market Size Market Share by Application (2017-2028)
Figure 24. North America Oncology Small Molecule Drugs Market Size Share by Country (2017-2028)
Figure 25. United States Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Canada Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Europe Oncology Small Molecule Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 28. Europe Oncology Small Molecule Drugs Market Size Market Share by Type (2017-2028)
Figure 29. Europe Oncology Small Molecule Drugs Market Size Market Share by Application (2017-2028)
Figure 30. Europe Oncology Small Molecule Drugs Market Size Share by Country (2017-2028)
Figure 31. Germany Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. France Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. U.K. Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Italy Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Russia Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Nordic Countries Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Asia-Pacific Oncology Small Molecule Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 38. Asia Pacific Oncology Small Molecule Drugs Market Size Market Share by Type (2017-2028)
Figure 39. Asia Pacific Oncology Small Molecule Drugs Market Size Market Share by Application (2017-2028)
Figure 40. Asia Pacific Oncology Small Molecule Drugs Market Size Share by Region (2017-2028)
Figure 41. China Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Japan Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. South Korea Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Southeast Asia Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. India Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Australia Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 47. Latin America Oncology Small Molecule Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Latin America Oncology Small Molecule Drugs Market Size Market Share by Type (2017-2028)
Figure 49. Latin America Oncology Small Molecule Drugs Market Size Market Share by Application (2017-2028)
Figure 50. Latin America Oncology Small Molecule Drugs Market Size Share by Country (2017-2028)
Figure 51. Mexico Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Brazil Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Middle East & Africa Oncology Small Molecule Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 54. Middle East and Africa Oncology Small Molecule Drugs Market Size Market Share by Type (2017-2028)
Figure 55. Middle East and Africa Oncology Small Molecule Drugs Market Size Market Share by Application (2017-2028)
Figure 56. Middle East and Africa Oncology Small Molecule Drugs Market Size Share by Country (2017-2028)
Figure 57. Turkey Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. Saudi Arabia Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 59. UAE Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 60. Roche Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 61. Novartis Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 62. Pfizer Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 63. Celgene Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 64. Bristol-Myers Squibb Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 65. Amgen Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 66. Johnson & Johnson Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 67. AbbVie Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 68. Sanofi Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 69. Takeda Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 70. Eli Lilly Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 71. Bayer Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 72. AstraZeneca Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 73. Astellas Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 74. Merck Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 75. Biogen Idec Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 76. Eisai Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 77. Teva Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 78. Otsuka Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 79. Ipsen Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 80. Gilead Sciences Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 81. Exelixis Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed
